RSPH vs. PBPH
RSPH (Invesco S&P 500 Equal Weight Health Care ETF) and PBPH (Portfolio Building Block World Pharma and Biotech Index ETF) are both Health & Biotech Equities funds - RSPH tracks the S&P 500 Equal Weighted / Health Care -SEC while PBPH tracks the BITA Global Pharma and Biotech Select Index. Both are passively managed. A 0.65 correlation means they provide meaningful diversification when combined. RSPH charges 0.40%/yr vs 0.13%/yr for PBPH.
Performance
RSPH vs. PBPH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RSPH achieves a -2.71% return, which is significantly lower than PBPH's -1.13% return.
RSPH
- 1D
- 0.81%
- 1M
- 2.49%
- YTD
- -2.71%
- 6M
- -2.70%
- 1Y
- 8.70%
- 3Y*
- 3.21%
- 5Y*
- 2.54%
- 10Y*
- 7.94%
PBPH
- 1D
- 0.58%
- 1M
- 0.07%
- YTD
- -1.13%
- 6M
- -0.02%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
RSPH vs. PBPH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
RSPH Invesco S&P 500 Equal Weight Health Care ETF | -2.71% | -1.99% |
PBPH Portfolio Building Block World Pharma and Biotech Index ETF | -1.13% | 0.76% |
Correlation
The correlation between RSPH and PBPH is 0.65, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Nov 26, 2025 | 0.65 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RSPH vs. PBPH — Risk / Return Rank
RSPH
PBPH
RSPH vs. PBPH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco S&P 500 Equal Weight Health Care ETF (RSPH) and Portfolio Building Block World Pharma and Biotech Index ETF (PBPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| RSPH | PBPH | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.57 | — | — |
Sortino ratioReturn per unit of downside risk | 0.91 | — | — |
Omega ratioGain probability vs. loss probability | 1.11 | — | — |
Calmar ratioReturn relative to maximum drawdown | 0.80 | — | — |
Martin ratioReturn relative to average drawdown | 2.01 | — | — |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| RSPH | PBPH | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.57 | — | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.16 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.45 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.58 | -0.04 | +0.62 |
Drawdowns
RSPH vs. PBPH - Drawdown Comparison
The maximum RSPH drawdown since its inception was -40.49%, which is greater than PBPH's maximum drawdown of -11.10%. Use the drawdown chart below to compare losses from any high point for RSPH and PBPH.
Loading charts...
Drawdown Indicators
| RSPH | PBPH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -40.49% | -11.10% | -29.39% |
Max Drawdown (1Y)Largest decline over 1 year | -10.87% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -17.13% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -21.95% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -30.44% | — | — |
Current DrawdownCurrent decline from peak | -6.83% | -8.69% | +1.86% |
Average DrawdownAverage peak-to-trough decline | -6.14% | -4.23% | -1.91% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.33% | — | — |
Volatility
RSPH vs. PBPH - Volatility Comparison
Loading charts...
Volatility by Period
| RSPH | PBPH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 3.87% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 10.36% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 15.46% | 16.78% | -1.32% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.26% | 16.78% | -0.52% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.72% | 16.78% | +0.94% |
RSPH vs. PBPH - Expense Ratio Comparison
RSPH has a 0.40% expense ratio, which is higher than PBPH's 0.13% expense ratio.
Dividends
RSPH vs. PBPH - Dividend Comparison
RSPH's dividend yield for the trailing twelve months is around 0.73%, more than PBPH's 0.09% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PBPH Portfolio Building Block World Pharma and Biotech Index ETF | 0.09% | 0.09% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
RSPH Invesco S&P 500 Equal Weight Health Care ETF | 0.73% | 0.70% | 0.71% | 0.66% | 0.64% | 0.50% | 0.51% | 0.54% | 0.53% | 0.47% | 0.48% | 0.49% |
Frequently Asked Questions
RSPH and PBPH have a correlation of 0.65, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, PBPH is cheaper at 0.13% per year. The better choice depends on whether you care most about return, fees, risk, or income.
PBPH is cheaper with a 0.13% expense ratio, compared with 0.40% for RSPH.
RSPH has the higher dividend yield at 0.73%, compared with 0.09% for PBPH.
RSPH tracks S&P 500 Equal Weighted / Health Care -SEC, while PBPH tracks BITA Global Pharma and Biotech Select Index. They also come from different issuers: Invesco and Portfolio Building Block. Their fees differ too: 0.40% for RSPH and 0.13% for PBPH.
Find the right allocation for RSPH and PBPH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer